The Pulmonary Fibrosis-Associated MUC5B Promoter Polymorphism Does Not Influence the Development of Interstitial Pneumonia in Systemic Sclerosis
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A Variant in the Promoter ofMUC5Band Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2011
- A CommonMUC5BPromoter Polymorphism and Pulmonary FibrosisNew England Journal of Medicine, 2011
- NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesisAnnals of the Rheumatic Diseases, 2011
- Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locusNature Genetics, 2010
- Imaging Lung Disease in Systemic SclerosisCurrent Rheumatology Reports, 2010
- STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosisArthritis & Rheumatism, 2009
- Anti–U11/U12 RNP antibodies in systemic sclerosis: A new serologic marker associated with pulmonary fibrosisArthritis Care & Research, 2009
- Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: A new perspective for pulmonary fibrosisArthritis & Rheumatism, 2008
- Systemic sclerosis: a prototypic multisystem fibrotic disorderJournal of Clinical Investigation, 2007
- Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosisArthritis & Rheumatism, 1988